Hypertrophic cardiomyopathy and ischemic heart disease: the problem of pathology combination
https://doi.org/10.18087/cardio.2386
Abstract
Hypertrophic cardiomyopathy (HCM) is a disease with left ventricular hypertrophy caused by mutations in the genes of myocardial contractile proteins, whose frequency is about 0.5%. Due to the high incidence of anginal pain and marked changes in ECG with HCM, the problem of diagnosing the combination of HCM and coronary artery disease (CAD) presents a rather difficult task for the clinician. The complexity of this diagnosis is due to the ability of standard methods of instrumental examination (ECG, a test with physical activity, stress tests in conjunction with visualization of the myocardium) to detect myocardial ischemia in both CAD and HCM. In such cases, the coronary angiography, or multispiral computed tomography of coronary arteries (in patients with low CAD risk) remains the gold standard for detecting atherosclerotic lesions of the coronary arteries. The possibility of combining HCM and CAD in patients of older age groups raises the question of the features of the course of diseases and the prognosis of such patients.
About the Authors
E. A. Kovalevskaya
Pirogov Russian National Research Medical University; Qty clinical hospital no 52
Russian Federation
Russian Federation
N. S. Krylova
Pirogov Russian National Research Medical University; Qty clinical hospital no 52
Russian Federation
Russian Federation
N. G. Poteshkina
Pirogov Russian National Research Medical University; Qty clinical hospital no 52
Russian Federation
Russian Federation
References
1. Authors/Task Force members, Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014;35 (39):2733-79. D01:10.1093/eurheartj/ehu284
2. Maron BJ, Maron MS. Hypertrophic cardiomyopathy. Lancet. 2013;381 (9862):242-55. D0I:10.1016/S0140-6736(12)60397-3
3. Полякова А. А., Семернин Е. Н., Стрельцова А. А., Гудкова Р. Г. Особенности гипертрофической кардиомиопатии у пожилых пациентов. Артериальная гипертензия. 2013;19 (6):502-5.
4. Sado DM, Iqbal J. Hypertrophic cardiomyopathy in older patients. Clin Med (Lond). 2010;10 (2):196-8. PMID:20438000
5. Maron BJ, Casey SA, Haas TS, Kitner CL, Garberich RF, Lesser JR. Hypertrophic cardiomyopathy with longevity to 90 years or older. Am J Cardiol. 2012;109 (9):1341-7. D0I:10.1016/j.amjcard. 2011.12.027
6. Maron BJ, Rowin EJ, Casey SA, Haas TS, Chan RHM, Udelson JE et al. Risk stratification and outcome of patients with hypertrophic cardiomyopathy >=60 years of age. Circulation. 2013;127 (5):585-93. D0I:10.1161/CIRCULATI0NAHA.112.136085
7. Клинические рекомендации по диагностике и лечению кардиомиопатий (гипертрофическая). Евразийский кардиологический журнал. 2014; (3):4-23.
8. Беленков Ю. Н., Привалова Е. В., Каплунова В. Ю. Гипертрофическая кардиомиопатия. -М.: ГЭОТАР-Медиа; 2011. 392 с.
9. Raphael CE, Cooper R, Parker KH, Collinson J, Vassiliou V, Pennell DJ et al. Mechanisms of Myocardial Ischemia in Hypertrophic Cardiomyopathy: Insights From Wave Intensity Analysis and Magnetic Resonance. J Am Coll Cardiol. 2016;68 (15):1651-60. D0I:10.1016/j.jacc.2016.07.751
10. Maron MS, 0livotto I, Maron BJ, Prasad SK, Cecchi F, Udelson JE et al. The case for myocardial ischemia in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2009;54 (9):866-75. D0I:10.1016/ j.jacc.2009.04.072
11. Якушин С. С., Филиппов Е. В. Гипертрофическая кардиомиопатия и сочетанная кардиологическая патология: особенности диагностики и лечения. Архивъ внутренней медицины. 2011; (1):29-34.
12. Ushikoshi H, 0kada H, Morishita K, Imai H, Tomita H, Nawa T et al. An autopsy report of acute myocardial infarction with hypertrophic obstructive cardiomyopathy-like heart. Cardiovasc Pathol. 2015;24 (6):405-7. D0I:10.1016/j.carpath.2015.07.004
13. Sorajja P, Ommen SR, Nishimura RA, Gersh BJ, Berger PB, Tajik AJ. Adverse prognosis of patients with hypertrophic cardiomyopathy who have epicardial coronary artery disease. Circulation. 2003;108 (19):2342-8. D0I:10.1161/01.CIR.0000097110.55312.BF
14. Shin DG, Son J-W, Park JY, Choi JW, Ryu SK. Impact of coronary artery anatomy on clinical course and prognosis in apical hypertrophic cardiomyopathy: analysis of coronary angiography and computed tomography. Korean Circ J. 2015;45 (1):38-43. D0I:10.4070/kcj.2015.45.1.38
15. Morise AP. Exercise testing in nonatherosclerotic heart disease: hypertrophic cardiomyopathy, valvular heart disease, and arrhythmias. Circulation. 2011;123 (2):216-25. D0I:10.1161/CIRCULATIONAHA. 109.914762
16. Argulian E, Chaudhry FA. Stress testing in patients with hypertrophic cardiomyopathy. Prog Cardiovasc Dis. 2012;54 (6):477-82. D0I:10.1016/j.pcad.2012.04.001
17. Cantor A, Yosefy C, Potekhin M, Ilia R, Keren A. The value of changes in QRS width and in ST-T segment during exercise test in hypertrophic cardiomyopathy for identification of associated coronary artery disease. Int J Cardiol. 2006;112 (1):99-104. D0I:10.1016/j.ijcard.2005.11.012
18. Gersh BJ, Maron BJ, Bonow R0, Dearani JA, Fifer MA, Link MS et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;124 (24):e783-831. D0I:10.1161/CIR.0b013e318223e2bd
19. Picano E, Ciampi Q, Citro R, D'Andrea A, Scali MC, Cortigiani L et al. Stress echo 2020: the international stress echo study in ischemic and non-ischemic heart disease. Cardiovasc Ultrasound. 2017;15 (1):3. D0I:10.1186/s12947-016-0092-1
20. Ciampi Q, 0livotto I, Gardini C, Mori F, Peteiro J, Monserrat L et al. Prognostic role of stress echocardiography in hypertrophic cardiomyopathy: The International Stress Echo Registry. Int J Cardiol. 2016;219:331-8. D0I:10.1016/j.ijcard.2016.06.044
21. Suzuki K, Akashi YJ. Exercise stress echocardiography in hypertrophic cardiomyopathy. J Echocardiogr. 2017;15 (3):110-7. D0I:10.1007/s12574-017-0338-4
22. Синицын В. Е., Мершина Е. А. Возможности магнитно-резонансной томографиии в диагностике кардиомиопатий. Клиническая и экспериментальная хирургия Журнал имени академика БВ Петровского. 2014; (1):54-63.
23. Chaikriangkrai K, Chebrolu L, Bhatti S, Chang SM. Diagnosis of ischemia in hypertrophic cardiomyopathy: role of computed tomography and nuclear stress testing. Curr 0pin Cardiol. 2015;30 (5):483-92. D0I:10.1097/HC0.0000000000000201
24. kayama S, Soeda T, Kawakami R, Takami Y, Somekawa S, Ueda T et al. Evaluation of coronary artery disease and cardiac morphology and function in patients with hypertrophic cardiomyopathy, using cardiac computed tomography. Heart Vessels. 2015;30 (1):28-35. D0I:10.1007/s00380-013-0452-9
25. Shariat M, Thavendiranathan P, Nguyen E, Wintersperger B, Paul N, Rakowski H et al. Utility of coronary CT angiography in outpatients with hypertrophic cardiomyopathy presenting with angina symptoms. J Cardiovasc Comput Tomogr. 2014;8 (6):429-37. D0I:10.1016/j.jcct.2014.09.007
26. Gupta T, Harikrishnan P, Kolte D, Khera S, Aronow WS, Mujib M et al. 0utcomes of acute myocardial infarction in patients with hypertrophic cardiomyopathy. Am J Med. 2015;128 (8):879-887. e1. D0I:10.1016/j.amjmed.2015.02.025
27. Yang Y-J, Fan C-M, Yuan J-Q, Zhang H-B, Duan F-J, Wang Z-M et al. Long-term survival after acute myocardial infarction in patients with hypertrophic cardiomyopathy. Clin Cardiol. 2017;40 (1):26-31. D0I:10.1002/clc.22601
Review
For citations:
Kovalevskaya E.A., Krylova N.S., Poteshkina N.G. Hypertrophic cardiomyopathy and ischemic heart disease: the problem of pathology combination. Kardiologiia. 2018;58(1S):31-35. (In Russ.) https://doi.org/10.18087/cardio.2386
Views:
1184
Email this article 
Post a Comment 
